Recruiting OBSERVATIONAL NCT06601075
The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
Sponsor: Ruijin Hospital
Conditions
Advanced Colorectal Cancer
Updated 3 times since 2024 Last updated: Jan 20, 2025 Started: Feb 1, 2025 Primary completion: Mar 31, 2026 Completion: Mar 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Advanced Colorectal Cancer, this trial is actively recruiting participants. The trial is conducted by Ruijin Hospital and has accumulated 3 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
3 versions recorded-
Feb 2025 — Present [monthly]
Recruiting
-
Jan 2025 — Feb 2025 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Jan 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ruijin Hospital
Data source: Ruijin Hospital
For direct contact, visit the study record on ClinicalTrials.gov .